At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Pyridoxal 5'-Phosphate (100 mg) (supplement), Placebo (other)
- How long the study runs
- Study runs about 24 months (dates as stated)
- About the drug or intervention
- Pyridoxal 5'-Phosphate (100 mg) — supplement: 100 mg Pyridoxal 5'-Phosphate tablet once daily with food · Placebo — other: Placebo tablet once daily
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years to 60 Years
- Who
- All
- Number of participants
- 40
- Started
- 2024-11-08
- Last checked
- 2026-10
Plain English Summary
What is this study?
- • Testing a new treatment for autism
- • NA - 40 participants
- • This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults
Who can take part?
- • Ages 18 Years to 60 Years
- • Diagnosed with autism
Where?
- • Reading - University of Reading
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.
More detail
The main question it aims to answer is: * Does high-dose Vitamin B6 supplementation reduce sensory hyperreactivity differences in autism? * Does high-dose Vitamin B6 supplementation reduce anxiety differences in autism? * Explore the effects of vitamin B6 on sleep quality, Attention Deficit Hyperactivity Disorder (ADHD) scores, and various visual perception tasks that are indicative of GABAergic activity
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years - 60 Years
- Who can join: All genders
What the study is looking for
- ✓Between the ages of 18 to 60
- ✓With a diagnosis of autism
Who cannot take part
- ✗Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs
- ✗Have a medical history of peripheral neuropathy
- ✗lactose intolerance (placebo tablet is lactose based)
See the full criteria
Where Is This Study? (1 UK site)
University of Reading
Reading RG6 6AL, United Kingdom
How to Get in Touch
Dr David T Field, PhD
Sponsor contactCONTACT
Alex Cameron, MSc
Sponsor contactCONTACT
